ORBIMED ADVISORS LLC – EyePoint Pharmaceuticals, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$7.68M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+0.51%
quarter
EyePoint Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +353.46% | 756.76K shares | 5.99M | $7.91 | 970.86K |
| Q2 2022 | share | Increase | 0.00% | 214.1K shares | 1.68M | $7.87 | 214.1K |